REVIEW ON PICK´S DISEASE
Abstract
Keywords
Full Text:
PDFReferences
.Olney NT, Spina S, Miller BL. Frontotemporal Dementia. Neurol Clin. 2017 May;35(2):339-374.
.Hofmann JW, Seeley WW, Huang EJ, Kubota M (24 January 2019). “RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration”. Annual Review of Pathology. 14: 469–495. Doi:10.1146/annurev-pathmechdis-012418-012955. PMC 6731550. PMID : 30355151.
.Rabinovici GD, Miller BL (May 2010). “Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management”. CNS Drugs. 24 (5): 375–98. Doi:10.2165/11533100-000000000-00000. PMC 2916644. PMID 20369906.
. Paulsen JS, Gehl C. Neuropsychology. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff’s Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 44.
.McKhann, G. M., M. S.Albert, M.Grossman, B.Miller, D.Dickson, and J. Q.Trojanowski. Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and Pick’s disease.Arch Neurol2001. 58:1803–1809.
.Bird, T. D. Genotypes, phenotypes, and frontotemporal dementia: take your pick. Neurology 1998. 50:1527–1528.
.Onyike CU, Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int Rev Psychiatry. 2013 Apr;25(2):130-7.
. Cardarelli R, Kertesz A, Knebl JA (December 2010). “Frontotemporal dementia: a review for primary care physicians”. Am Fam Physician. 82 (11): 1372–7. PMID 21121521.
.Rabinovici GD, Miller BL (May 2010). “Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management”. CNS Drugs. 24 (5): 375–98. Doi:10.2165/11533100-000000000-00000. PMC 2916644. PMID 20369906.
.Snowden JS, Neary D, Mann DM (February 2002). “Frontotemporal dementia”. Br J Psychiatry. 180 (2): 140–3. Doi:10.1192/bjp.180.2.140. PMID 1182332.
DOI: https://doi.org/10.37591/(rrjops).v14i1.1287
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Research and Reviews: A Journal of Pharmaceutical Science